Skip to content

Prospective cohort study of acupoint sensitization and regularity of chronic stable angina

Clinical epidemiological study on acupoint sensitization and regularity of chronic stable angina pectoris: prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018626
Enrollment
Unknown
Registered
2018-09-30
Start date
2018-10-15
Completion date
Unknown
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic stable angina

Interventions

Acupoint sensitivity cohort vs non acupoint sensitivity cohort:Nil

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Aged 35 to 80 years old male and female; (2) The following six items met: patients with previous myocardial infarction; after PCI; coronary CT showed coronary stenosis more than 50%; coronary angiography showed coronary stenosis more than 50%; exercise plate electrocardiogram was positive; electrocardiogram had Myocardial ischemia changes; (3) The onset time was 3 months or more, and there were no more than 2 episodes in the past month; there was no change in the frequency, duration, cause or mitigation of angina pectoris in the past 60 days; (4) Compliance is good, and willing to cooperate with the study, the patient signed the informed consent form. Note: Patients who meet the above four items can be included in the study.

Exclusion criteria

Exclusion criteria: (1) Patients with severe primary diseases such as cardiovascular, digestive, urinary, respiratory, blood, neurological, and endocrine systems failing to effectively control the disease; (2) patients with acute coronary syndrome (including acute myocardial infarction, unstable angina), severe arrhythmia (severe atrioventricular block, ventricular tachycardia, supraventricular tachycardia affecting kinetics) Frequent premature beats, especially ventricular premature beats, atrial fibrillation), primary cardiomyopathy, valvular heart disease; (3) valvular heart disease, hypertrophic cardiomyopathy, chest pain caused by dilated cardiomyopathy; chest pain caused by non-cardiac disease (severe neurosis; or menopausal syndrome; or cervical spondylosis; or esophageal, pulmonary or chest wall Chest pain, etc.); (4) Those with mental disorders and mental disorders cannot cooperate with the questionnaire; (5) The patient's hypertension and diabetes clinical treatment did not meet the target; (6) Severe anemia (Hb < 70 g/l). Note: Any patient who meets any of the above is excluded.

Design outcomes

Primary

MeasureTime frame
Body surface temperature;Pressure pain threshold;Skin resistance;

Secondary

MeasureTime frame
Visual analogue scale (VAS);Seattle Angina Scale (SAQ);Canadian Cardiovascular Society (CCS) angina severity rating;

Countries

China

Contacts

Public ContactFanrong Liang

Chengdu University of Traditional Chinese Medicine

acu973@126.com+86 13608058216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026